Pharmaceutical Consulting Services

Alacrita's pharma consulting team provides precisely relevant support to pharma and biotech clients on a range of R&D and business issues. Our core team commands an expert network of 500+ top pharmaceutical professionals, enabling us to provide the same caliber of expertise of a specialist consulting firm, but replicated across multiple disciplines and therapeutic areas. We're the rare consulting firm able to offer you both depth and breadth in expertise.

Our team supports pharmaceutical & biotech organizations of all sizes, including start-ups, established companies, healthcare investors and academic institutions.

Pharmaceutical Consulting Services

Product
Development

Our expert teams are ready to support you through every step of product development, making sure you maximize value at each stage.

Strategy &
Commercialization

Our team of expert biopharma business consultants provides deep knowledge in critical areas such as company and portfolio strategies, fundraising pitch materials, platform or program opportunity-feasibility assessments, new product planning, value-based pricing and market access, and product launch preparations.

Business
Development

We dovetail with your in-house business development team to help find, evaluate and assess new assets, even taking responsibility for out-licensing your products to a pharma partner.

Why choose Alacrita?

Alacrita brings together a world-class network of over 500 pharmaceutical consultants, each highly skilled in their specialty area and hand-picked by us over the past decade. We've carefully curated our network to ensure we're providing our clients with only the highest-caliber of expertise available. 

Our core team of partners form the keystone of every consulting project. Each brings at least 20 years of pharmaceutical industry experience, along with deep domain knowledge, senior business expertise and executive-level skillsets.

Alacrita core partners & consultants leverage our expert network, creating a combination that allows us to support clients at each stage of their project or company, with expertise that is precisely targeted to their specific need. Being a provider of specialized support across a range of disciplines and stages, we're able to bring additional strategic and industry insight to every project.

Therapeutic areas and technologies we have experience with:

Therapeutic Areas

  • Autoimmune/Immunology
  • Cardiovascular
  • Central Nervous System
  • Congenital Disorders
  • Dermatology/Aesthetics
  • Digestive/GI
  • Ear
  • Endocrine and Metabolic
  • Fibrosis
  • Genitourinary Diseases
  • Haematology
  • Infectious Disease
  • Inflammation/Pain
  • Injuries and Trauma
  • Musculoskeletal
  • Non-medical
  • Oncology
  • Ophthalmology
  • Orphan Diseases
  • Respiratory
  • Urology (non-onc)
  • Women’s Health

Technologies

  • Imaging
  • Immunotherapy
  • Medtech
  • Microbiome
  • Oncolytic Virus
  • Peptides
  • Proteins
  • Radiopharmaceuticals
  • Small molecules
  • Vaccines

Pharmaceutical Consulting Case Studies | View all

DD of a clinical stage therapeutic for rare neurodegenerative disorders

Challenge: A pharma company developing a first-in-class therapeutic to treat rare paediatric neurodegenerative disorders was nearing NDA approval in multiple indications and was ready to...

Ongoing Due Diligence Support

Challenge: A midsize speciality pharmaceuticals company has retained Alacrita to conduct a series of due diligence assessments to support its business development function. The client...

Commercial supply chain for US launch of a blood cancer drug

Challenge: Our client was a publicly-traded clinical-stage biopharmaceutical company using an epigenetic approach modulate gene expression in tumor and immune cells to treat cancer. Their...

Due Diligence of Late Stage Gene Therapy Asset

Challenge: Our client, a global pharmaceutical company, was facing a short deadline to making an offer for a late stage gene therapy asset and was under considerable competitive deal...

Landscape Analysis of the Radiopharma Market

Challenge: A VC investor considering funding a radiopharmaceutical company requested an analysis of the therapeutic radiopharmaceutical landscape, to help them evaluate the investment. The...

Pharmaceutical Licensing: Negotiation Support

Alacrita provides support to organizations seeking pharmaceutical licensing opportunities, both in- and out-licensing, as well as negotiation support. Our approach is flexible and can be...